214 related articles for article (PubMed ID: 24135759)
1. Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype.
Kuriyan AE; Woeller CF; O'Loughlin CW; Phipps RP; Feldon SE
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7370-7. PubMed ID: 24135759
[TBL] [Abstract][Full Text] [Related]
2. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
[TBL] [Abstract][Full Text] [Related]
3. Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.
Draman MS; Grennan-Jones F; Zhang L; Taylor PN; Tun TK; McDermott J; Moriarty P; Morris D; Lane C; Sreenan S; Dayan C; Ludgate M
Thyroid; 2013 Dec; 23(12):1600-8. PubMed ID: 24001049
[TBL] [Abstract][Full Text] [Related]
4. The Potential of Artemisinins as Novel Treatment for Thyroid Eye Disease by Inhibiting Adipogenesis in Orbital Fibroblasts.
Guo Y; Cheng Y; Li H; Guan H; Xiao H; Li Y
Invest Ophthalmol Vis Sci; 2023 Jun; 64(7):28. PubMed ID: 37326592
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy.
Fang S; Huang Y; Zhong S; Li Y; Zhang Y; Li Y; Sun J; Liu X; Wang Y; Zhang S; Xu T; Sun X; Gu P; Li D; Zhou H; Li B; Fan X
J Clin Endocrinol Metab; 2017 Nov; 102(11):4273-4283. PubMed ID: 28938397
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A inhibits PDGF-BB induced hyaluronan synthesis in orbital fibroblasts.
Galgoczi E; Molnar Z; Katko M; Ujhelyi B; Steiber Z; Nagy EV
Chem Biol Interact; 2024 Jun; 396():111045. PubMed ID: 38729283
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic Profiling of Control and Thyroid-Associated Orbitopathy (TAO) Orbital Fat and TAO Orbital Fibroblasts Undergoing Adipogenesis.
Kim DW; Taneja K; Hoang T; Santiago CP; McCulley TJ; Merbs SL; Mahoney NR; Blackshaw S; Rajaii F
Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):24. PubMed ID: 34269815
[TBL] [Abstract][Full Text] [Related]
8. Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an
Wang X; Yang S; Ye H; Chen J; Shi L; Feng L; Wang X; Zhang T; Chen R; Xiao W; Yang H
Thyroid; 2022 Mar; 32(3):294-305. PubMed ID: 34605662
[No Abstract] [Full Text] [Related]
9. TGFβ-Treated Placenta-Derived Mesenchymal Stem Cells Selectively Promote Anti-Adipogenesis in Thyroid-Associated Ophthalmopathy.
Shin HA; Park M; Banga JP; Lew H
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628410
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-130a Is Elevated in Thyroid Eye Disease and Increases Lipid Accumulation in Fibroblasts Through the Suppression of AMPK.
Hammond CL; Roztocil E; Gonzalez MO; Feldon SE; Woeller CF
Invest Ophthalmol Vis Sci; 2021 Jan; 62(1):29. PubMed ID: 33507228
[TBL] [Abstract][Full Text] [Related]
11. TSHR Signaling Stimulates Proliferation Through PI3K/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts.
Woeller CF; Roztocil E; Hammond C; Feldon SE
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4336-4345. PubMed ID: 31622470
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin F2α Regulates Adipogenesis by Modulating Extracellular Signal-Regulated Kinase Signaling in Graves' Ophthalmopathy.
Zhu R; Wang XH; Wang BW; Ouyang X; You YY; Xie HT; Zhang MC; Jiang FG
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108173
[TBL] [Abstract][Full Text] [Related]
13. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
Park M; Banga JP; Kim GJ; Kim M; Lew H
Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
Ko J; Kim JY; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4477-4485. PubMed ID: 30193323
[TBL] [Abstract][Full Text] [Related]
15. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
Xiong H; Wu M; Zou H; Jiang S; Yi H; Yi T; Wang Q; Liu D; Zhou Y; Wei C; Zhou X
Mol Vis; 2018; 24():509-517. PubMed ID: 30090014
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoke extract-induced adipogenesis in Graves' orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress.
Yoon JS; Lee HJ; Chae MK; Lee SY; Lee EJ
J Endocrinol; 2013 Feb; 216(2):145-56. PubMed ID: 23143154
[TBL] [Abstract][Full Text] [Related]
17. Wnt signalling inhibits adipogenesis in orbital fibroblasts from patients with Graves' orbitopathy.
Jung SJ; Choi YJ; Park TK; Woo SE; Kim BY; Yoon JS; Jang SY
Br J Ophthalmol; 2022 Jul; 106(7):1019-1027. PubMed ID: 34193409
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves' Orbitopathy.
Shih SR; Liao SL; Shih CW; Wei YH; Lu TX; Chou CH; Yen EY; Chang YC; Lin CC; Chi YC; Yang WS; Tsai FC
Ocul Immunol Inflamm; 2021 Jan; 29(1):193-202. PubMed ID: 31657648
[No Abstract] [Full Text] [Related]
19. Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes.
Feldon SE; O'loughlin CW; Ray DM; Landskroner-Eiger S; Seweryniak KE; Phipps RP
Am J Pathol; 2006 Oct; 169(4):1183-93. PubMed ID: 17003477
[TBL] [Abstract][Full Text] [Related]
20. PRL-1 overexpressed placenta-derived mesenchymal stem cells suppress adipogenesis in Graves' ophthalmopathy through SREBP2/HMGCR pathway.
Park M; Kim JY; Kang JM; Lee HJ; Banga JP; Kim GJ; Lew H
Stem Cell Res Ther; 2021 May; 12(1):304. PubMed ID: 34051850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]